Abstract:Glioblastoma (GBM) is the most common malignant primary tumor in the human central nervous system. The present study aimed to explore the molecular mechanism by which microRNA (miR)-181a-5p targets the F-box protein 11 (FBXO11) in glioma cells to inhibit cell proliferation and invasion. Reverse transcription-quantitative (RT-q)PCR was performed to detect the expression levels of miR-181a-5p in U251TR cells, U251 cells, primary GBM tissues and relapsed GBM tissues in order to determine the association between miR-181a-5p and the chemoresistance of GBM cells. The expression levels of miR-181a-5p in GBM cells were modulated via transfecting miR-181a-5p mimics and inhibitors. Cell Counting Kit-8 assays were undertaken to assess the effects of miR-181a-5p on drug sensitivity and proliferation of GBM cells. Wound healing assays were performed to examine the effects of miR-181a-5p on the migratory ability of GBM cells. Furthermore, the effects of miR-181a-5p on the invasive ability of GBM cells were analyzed using an in vitro invasion assay. Flow cytometry analysis was carried out to determine whether overexpression of miR-181a-5p can promote the apoptotic rate of GBM cells. RT-qPCR and western blotting were employed to detect the effects of miR-181a-5p on mRNA and protein expression of FBX011. miR-181a-5p exhibited low expression in resistant GBM cell lines and recurrent tumor tissues. Dual-luciferase reporter assays were utilized to detect luciferase activity to verify the targeted regulatory association between miR-181a-5p and FBXO11. Upregulation of miR-181a-5p promoted the sensitivity of GBM cells to temozolomide (TMZ), increased the apoptotic rate of GBM cells and significantly inhibited the invasive and migratory capacities of GBM cells. In drug-resistant glioma cells, compared with the miR-negative control group and the blank group, the expression of miR-181a-5p was significantly upregulated (P<0.01), while the expression of FBXO11 protein was downregulated. miR-181a-5p increased the sensitivity of GBM cells to TMZ. miR-181a-5p significantly inhibited the migratory and invasive capacities of GBM cells. miR-181a-5p may become a novel effective target for the treatment of GBM. The results of dual-luciferase reporter assays indicated that miR-181a-5p could target the 3'-untranslated region of FBXO11. The underlying mechanism may be targeted inhibition of FBXO11 gene expression, or may be associated with apoptosis.

MicroRNA-144 Represses Gliomas Progression and Elevates Susceptibility to Temozolomide by Targeting CAV2 and FGF7

miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.

Long Non‑coding RNA LINC00473/miR‑195‑5p Promotes Glioma Progression Via YAP1‑TEAD1‑Hippo Signaling.

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.

Upregulation of miR-144-3p expression attenuates glioma cell viability and invasion by targeting BCL6

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1

MicroRNA-140-5p Inhibits Cell Proliferation and Invasion by Regulating VEGFA/MMP2 Signaling in Glioma

miR-152-5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7

miR-92b-3p Regulates Cell Progression and Drug Resistance through Upregulation of CXCL5 in Glioma

Microrna-301a/Znrf3/Wnt/Beta-Catenin Signal Regulatory Crosstalk Mediates Glioma Progression

MicroRNA-1179 Inhibits Glioblastoma Cell Proliferation and Cell Cycle Progression Via Directly Targeting E2F Transcription Factor 5.

MicroRNA-141-3p Promotes Glioma Cell Growth and Temozolomide Resistance by Directly Targeting P53

miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.

MicroRNA-1468-5p Inhibits Glioma Cell Proliferation and Induces Cell Cycle Arrest by Targeting RRM1.

MicroRNA-16 Inhibits Glioma Cell Growth and Invasion Through Suppression of BCL2 and the Nuclear Factor-Κb1/mmp9 Signaling Pathway.

MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5.

MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression

MicroRNA-338-5p Plays a Tumor Suppressor Role in Glioma Through Inhibition of the MAPK-signaling Pathway by Binding to FOXD1

Mir-181A-5p Inhibits the Proliferation and Invasion of Drug-Resistant Glioblastoma Cells by Targeting F-box Protein 11 Expression

MiR-760 Exerts a Critical Regulatory Role in Glioma Proliferation, Migration, and Invasion by Modulating MMP2 Expression